From a clinical perspective, however, it would be beneficial to target STAT3/14-3-3ζ interaction to inhibit the deleterious cooperation of 14-3-3ζ and STAT3 in cancer cells while sparing some of their essential homeostatic functions. This evidence concerns the gene STAT3 and cancer.